ArticleCellular and molecular gastroenterology and hepatology2022

Antagonizing STK25 Signaling Suppresses the Development of Hepatocellular Carcinoma Through Targeting Metabolic, Inflammatory, and Pro-Oncogenic Pathways.

Yeshwant Kurhe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.